SequelSEC

ProtoKinetix, Inc. PKTX

Pharmaceutical Preparations · CIK 0001128189 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2014-12-31
Operating income
Unavailable
Fiscal year ended 2014-12-31
Free cash flow
Unavailable
Fiscal year ended 2014-12-31

ProtoKinetix, Inc. (PKTX) reported revenue of $0 and net income of -$168.48K for the fiscal year ended 2014-12-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from ProtoKinetix, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

ProtoKinetix, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2014-12-31
Revenue$0
Cost of revenueUnavailable
Gross profitUnavailable
Operating incomeUnavailable
Net income-$168.48K
Research & development$13.75K
Weighted-average diluted sharesshares 172.40M
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$141.50K
Selling & marketingUnavailable

Balance

ProtoKinetix, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2014-12-31
Cash & equivalentsUnavailable
Total assets$5.81K
Current assets$5.81K
Total liabilities$434.14K
Current liabilitiesUnavailable
Total equity incl. NCI-$428.33K
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$5.50K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

ProtoKinetix, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2014-12-31
Operating cash flow-$229.25K
Capital expendituresUnavailable
Investing cash flow$30.00K
Financing cash flow$196.50K
Net change in cash-$2.75K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

ProtoKinetix, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2014-12-31
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratioUnavailable
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PKTX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-09-03View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-03-28View SEC filing
10-Q · Filed 2024-11-12View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.